Regional lymphotropic therapy used in complex treatment of patients with new-onset pulmonary tuberculosis enhances its efficiency. It is well tolerated by patients and easy-to-use. The pharmacokinetic feature of isoniazid during its lymphotropic administration is its shorter elimination half-life, decreased total clearance, and a larger area under the pharmacokinetic curve.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
lymphotropic therapy
8
patients new-onset
8
new-onset pulmonary
8
[the clinical
4
clinical pharmacokinetic
4
pharmacokinetic features
4
features lymphotropic
4
therapy patients
4
pulmonary tuberculosis]
4
tuberculosis] regional
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!